Certara to Open New Office in China
The new office will provide the company with opportunities to collaborate more efficiently with customers in the Chinese biopharmaceutical industry.
Certara, a US-based biosimulation company, is opening a new office in Shanghai, China’s Pudong District, a hub for biopharmaceutical research and development.
The new office will provide the company with opportunities to collaborate more efficiently with customers in the Chinese biopharmaceutical industry, a Nov. 9, 2020 company press release said.
“We recognize the tremendous growth of China’s biopharmaceutical industry and are thrilled to have a direct presence in China so that we can fully support our rapidly growing Chinese customer base,” said William F. Feehery, PhD, CEO of Certara, in the press release. “Certara’s extensive experience in biosimulation and our partnerships with top global biopharmaceutical companies will help foster innovation in China, accelerate time-to-market for our customers, and most importantly, improve patient outcomes.”
Source: Certara
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
